Skip to content

Bluebird Bio Finance Chief Is Second to Depart in 6 Months

Updated on

Bluebird Bio Inc. Chief Strategy and Financial Officer Jason Cole will step down “to pursue new career opportunities,” the second executive to depart the role at the struggling biotech in six months. 

Cole’s last day at Bluebird will be Oct. 14, according to a statement, although he’ll advise the company on strategy through April. Katherine Breedis of Danforth Advisors will serve as Bluebird’s interim chief financial officer as the company starts an external search for a permanent replacement.